The DOI matches its Crossref record.
Developing Drugs For Developing Countries
Open accessAbstract
Infectious and parasitic diseases create enormous health burdens, but because most of the people suffering from these diseases are poor, little is invested in developing treatments. We propose that developers of treatments for neglected diseases receive a "priority review voucher." The voucher could save an average of one year of U.S. Food and Drug Administration (FDA) review and be sold by the developer to the manufacturer of a blockbuster drug. In a well-functioning market, the voucher would speed access to highly valued treatments. Thus, the voucher could benefit consumers in both developing and developed countries at relatively low cost to the taxpayer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Technologies for global health
Howitt, P., Darzi, A., Yang, G.-Z., Ashrafian, H., Atun, R., Barlow, J., Blakemore, A., Bull, A. M., Car, J., Conteh, L., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61127-1 · Cited by 373
Driving a decade of change: HIV/AIDS, patents and access to medicines for all
Hoen, E. '., Berger, J., Calmy, A., & Moon, S. (2011) · Journal of the International AIDS Society · doi:10.1186/1758-2652-14-15 · Cited by 334
Do Firms Underinvest in Long-Term Research? Evidence from Cancer Clinical Trials
Budish, E., Roin, B. N., & Williams, H. (2015) · American Economic Review · doi:10.1257/aer.20131176 · Cited by 302
Priorities for the Priority Review Voucher
Ridley, D. B. (2017) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0600 · Cited by 15
Self-citation
Metadata
- Authors
- Ridley, D. B., Grabowski, H. G., & Moe, J. L.
- Venue
- Health Affairs
- Publisher
- Health Affairs Publishing, LLC
- Published
- 2006-03
- Volume
- 25
- Issue
- 2
- Pages
- 313-324
- ISSN
- 0278-2715 (ISSN-L)
- 1544-5208
- OpenAlex
- W2168063373
- Cited by
- 198
- References
- 0
- FWCI
- 23.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.